Company News: King Pharmaceuticals

Share this article:
King Pharmaceuticals reported full-year revenue up 14% to $1.78 billion. Highlights of the year included the company's acquisition of Alpharma and winning US marketing approval for pain drug Embeda.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.